Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pathology|September 8, 2011
Cellular therapy to treat haematological and other malignancies: progress and pitfallsPhillip D Fromm, David Gottlieb, Kenneth F Bradstock, et al.
Frontiers in Microbiology|February 3, 2016
Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 ResponsePhillip D Fromm, Jessica C Kling, Annika Remke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2012
Loss of TNF signaling facilitates the development of a novel Ly-6C(low) macrophage population permissive for Leishmania major infectionPhillip D Fromm, Jessica Kling, Matthias Mack, et al.
Seminars in Cell & Developmental Biology|February 18, 2018
Dendritic cells as cancer therapeuticsChristian E Bryant, Sarah Sutherland, Benjamin Kong, et al.
Frontiers in Oncology|February 22, 2019
On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer ImmunotherapyBenjamin Y Kong, Holly Bolton, Julius W Kim, et al.
Chemmedchem|April 8, 2011
Mechanism of cytotoxicity and cellular uptake of lipophilic inert dinuclear polypyridylruthenium(II) complexesMichelle J Pisani, Phillip D Fromm, Yanyan Mulyana, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2017
Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damageJinwen Tu, Shihani Stoner, Phillip D Fromm, et al.
Immunology and Cell Biology|April 17, 2013
CCR6 is transiently upregulated on B cells after activation and modulates the germinal center reaction in the mouseFlorian Wiede, Phillip D Fromm, Iain Comerford, et al.
Pharmacological Reviews|August 5, 2015
Dendritic Cells as Pharmacological Tools for Cancer ImmunotherapySébastien Anguille, Evelien L Smits, Christian Bryant, et al.
Pageof 2